LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.24 | 21.74 | 1022 | 6162 | 0.1659 | 0.6042 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.24 | 21.74 | 1242 | 6162 | 0.2016 | 0.6430 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.24 | 21.74 | 1254 | 6162 | 0.2035 | 0.6450 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.21 | 21.74 | 388 | 6235 | 0.0622 | 0.4233 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.21 | 21.74 | 1016 | 6235 | 0.1629 | 0.6014 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.21 | 21.74 | 1243 | 6235 | 0.1993 | 0.6415 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.21 | 21.74 | 1253 | 6235 | 0.2009 | 0.6431 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 76.18 | 21.74 | 445 | 6114 | 0.0728 | 0.4493 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 76.18 | 21.74 | 1031 | 6114 | 0.1686 | 0.6070 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 76.18 | 21.74 | 1234 | 6114 | 0.2018 | 0.6429 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 76.18 | 21.74 | 1247 | 6114 | 0.2040 | 0.6450 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 78.15 | 21.74 | 458 | 6167 | 0.0743 | 0.4536 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 78.15 | 21.74 | 1025 | 6167 | 0.1662 | 0.6046 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 78.15 | 21.74 | 1234 | 6167 | 0.2001 | 0.6416 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 78.15 | 21.74 | 1244 | 6167 | 0.2017 | 0.6432 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 80.12 | 21.74 | 467 | 6211 | 0.0752 | 0.4564 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 80.12 | 21.74 | 1038 | 6211 | 0.1671 | 0.6062 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 80.12 | 21.74 | 1256 | 6211 | 0.2022 | 0.6441 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 80.12 | 21.74 | 1262 | 6211 | 0.2032 | 0.6451 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.09 | 21.74 | 483 | 6201 | 0.0779 | 0.4626 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.09 | 21.74 | 1031 | 6201 | 0.1663 | 0.6051 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.09 | 21.74 | 1255 | 6201 | 0.2024 | 0.6442 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 82.09 | 21.74 | 1266 | 6201 | 0.2042 | 0.6460 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.06 | 21.74 | 497 | 6152 | 0.0808 | 0.4685 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 84.06 | 21.74 | 1041 | 6152 | 0.1692 | 0.6080 | MN20160310_N01 | E15 |